INVESTOR RESOURCES
iCHOR COMPANY INFORMATION, NEWS & PRESENTATIONS
Corporate Overview
iCHOR was founded by Interventional Radiologist Dr. Troy Long and industry veteran Tim Blair who saw an opportunity to develop new technologies to address the large unmet needs in treating peripheral vascular occlusions. They have devised a technology that has converted the tried and proven Fogarty balloon sweep method from an open surgery to a minimally-invasive endovascular procedure. The overall corporate objective is to focus on creating a one-size-fits-all system that replicates successful parameters of surgical clot removal while addressing the shortcomings of current therapeutic options. The Team’s long-term vision is for the iSWEEP system to become the standard of care and first-line therapy for treating peripheral vascular occlusions, increasing clinical flexibility while delivering improved outcomes at a lower cost. The iCHOR team consists of a group of experienced multi-disciplinary members, including entrepreneurs, executives, physicians, regulatory experts, and engineers. Together, we bring a broad range of experience in the development, regulatory approval, and commercialization of medical devices in the peripheral vascular space.
iCHOR at LSI '24
Medline Review Articles
The Latest News
Introducing the Adaptive Thrombectomy Platform
One simple mechanism that adapts to the clot, the vessel, and the site of care. Peripheral thrombectomy has outgrown the single-purpose device. Aspiration catheters suction, mechanical devices drag, and lytics dissolve. Each works well when the case matches its design. When it doesn’t, physicians switch devices, add lytics, or move the patient to the OR. The result is a vascular…
Dr Harris Provides Overview of iSWEEP Usage for Outpatient DVT Thrombectomy
In this new video, Dr Will Harris of the Vascular Institute of Chattanooga (VIC) provides an overview of iCHOR’s iSWEEP solution as a key tool for DVT thrombectomy procedures. Dr. Harris highlights that treating DVT with iCHOR in an outpatient setting avoids hospital admission, reduces costs, and achieves excellent clot clearance. The iCHOR system is self-contained and requires no accessory…